161 related articles for article (PubMed ID: 7030959)
21. Pathogenic mechanisms in neonatal GBS infection.
Ayoub EM; Swingle H
Antibiot Chemother (1971); 1985; 35():128-41. PubMed ID: 3901890
[No Abstract] [Full Text] [Related]
22. Influence of sialic contents on the chemiluminescent response of human leucocytes to group B streptococci.
De Paoli P; Mucignat C; Orefici G; Santini G
Microbiologica; 1985 Oct; 8(4):379-86. PubMed ID: 3906368
[TBL] [Abstract][Full Text] [Related]
23. Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.
VON Hunolstein C; Parisi L; Tissi L; Recchia S; Alfarone G; Nicolini L; Volpe C; Wagner B; Motlova J; Orefici G
J Med Microbiol; 1999 Nov; 48(11):983-990. PubMed ID: 10535641
[TBL] [Abstract][Full Text] [Related]
24. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
Marques MB; Kasper DL; Pangburn MK; Wessels MR
Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
[TBL] [Abstract][Full Text] [Related]
25. Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae.
Adderson EE; Takahashi S; Wang Y; Armstrong J; Miller DV; Bohnsack JF
Infect Immun; 2003 Dec; 71(12):6857-63. PubMed ID: 14638773
[TBL] [Abstract][Full Text] [Related]
26. Interaction with human plasminogen system turns on proteolytic activity in Streptococcus agalactiae and enhances its virulence in a mouse model.
Magalhães V; Veiga-Malta I; Almeida MR; Baptista M; Ribeiro A; Trieu-Cuot P; Ferreira P
Microbes Infect; 2007 Sep; 9(11):1276-84. PubMed ID: 17890121
[TBL] [Abstract][Full Text] [Related]
27. Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells.
Poyart C; Pellegrini E; Marceau M; Baptista M; Jaubert F; Lamy MC; Trieu-Cuot P
Mol Microbiol; 2003 Sep; 49(6):1615-25. PubMed ID: 12950925
[TBL] [Abstract][Full Text] [Related]
28. Mucin model for group B type III streptococcal infection in mice.
Fleming DO
Infect Immun; 1980 Feb; 27(2):449-54. PubMed ID: 6155334
[TBL] [Abstract][Full Text] [Related]
29. Possible virulence marker for Streptococcus agalactiae (Lancefield Group B).
Orefici G; Recchia S; Galante L
Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):302-5. PubMed ID: 3134236
[TBL] [Abstract][Full Text] [Related]
30. [Effect of the influenza A virus on the sensitivity of mice to infection caused by Streptococcus group B].
Bulgakova TN; Grabovskaia KB; Zueva OP
Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):23-9. PubMed ID: 3318226
[TBL] [Abstract][Full Text] [Related]
31. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci.
Mancuso G; Tomasello F; von Hunolstein C; Orefici G; Teti G
Infect Immun; 1994 Jul; 62(7):2748-53. PubMed ID: 8005664
[TBL] [Abstract][Full Text] [Related]
32. Natural Mutations in Streptococcus agalactiae Resulting in Abrogation of β Antigen Production.
Vasilyeva A; Santos Sanches I; Florindo C; Dmitriev A
PLoS One; 2015; 10(6):e0128426. PubMed ID: 26047354
[TBL] [Abstract][Full Text] [Related]
33. The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats.
Martin TR; Ruzinski JT; Rubens CE; Chi EY; Wilson CB
J Infect Dis; 1992 Feb; 165(2):306-14. PubMed ID: 1730897
[TBL] [Abstract][Full Text] [Related]
34. The sensor histidine kinase RgfC affects group B streptococcal virulence factor expression independent of its response regulator RgfA.
Gendrin C; Lembo A; Whidbey C; Burnside K; Berry J; Ngo L; Banerjee A; Xue L; Arrington J; Doran KS; Tao WA; Rajagopal L
Infect Immun; 2015 Mar; 83(3):1078-88. PubMed ID: 25561709
[TBL] [Abstract][Full Text] [Related]
35. Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells.
Nealon TJ; Mattingly SJ
Infect Immun; 1984 Feb; 43(2):523-30. PubMed ID: 6363289
[TBL] [Abstract][Full Text] [Related]
36. [Streptococci group B in human pathology].
Bulgakova TN; Grabovskaia KB; Totolian AA
Zh Mikrobiol Epidemiol Immunobiol; 1983 Aug; (8):7-17. PubMed ID: 6314711
[No Abstract] [Full Text] [Related]
37. Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico.
Palacios GC; Eskew EK; Solorzano F; Mattingly SJ
J Clin Microbiol; 1997 Nov; 35(11):2923-6. PubMed ID: 9350760
[TBL] [Abstract][Full Text] [Related]
38. Low prevalence of the immunoglobulin-A-binding beta antigen of the C protein among Streptococcus agalactiae isolates causing neonatal sepsis.
Berner R; Bender A; Rensing C; Forster J; Brandis M
Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):545-50. PubMed ID: 10517191
[TBL] [Abstract][Full Text] [Related]
39. Extracellular virulence factors of group B Streptococci.
Liu GY; Nizet V
Front Biosci; 2004 May; 9():1794-802. PubMed ID: 14977587
[TBL] [Abstract][Full Text] [Related]
40. Chicken embryo model for type III group B beta-hemolytic streptococcal septicemia.
Tieffenberg J; Vogel L; Kretschmer RR; Padnos D; Gotoff SP
Infect Immun; 1978 Feb; 19(2):481-5. PubMed ID: 344212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
